Cargando…
Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19
BACKGROUND: Allergen-specific immunotherapy (AIT) is accepted as the only disease-modifying therapy for IgE-mediated allergic airway diseases and hymenoptera venom allergy. AIT requires repeated contact between patient and physician or nurse in the hospital. Because it is a long-term treatment, comp...
Autores principales: | Erkoç, Merve, Öztürk, Betül Özdel, Mungan, Dilşad, Öztuna, Derya, Bavbek, Sevim, Demirel, Yavuz Selim, Aydın, Ömür, Sin, Betül Ayşe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819422/ https://www.ncbi.nlm.nih.gov/pubmed/35174057 http://dx.doi.org/10.5415/apallergy.2022.12.e6 |
Ejemplares similares
-
Coincidence of pollen season and coronavirus disease 2019 pandemic: less time outdoors – lesser allergy symptoms in 2020
por: Sözener, Zeynep Çelebi, et al.
Publicado: (2021) -
Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases
por: Celebi Sozener, Zeynep, et al.
Publicado: (2018) -
Anaphylaxis is rare due to CoronaVac in a population of healthcare workers
por: Öztürk, Betül Özdel, et al.
Publicado: (2022) -
Apples and pears serve the same purpose: Better diagnosis for anaphylaxis
por: Çolak, Sevgi, et al.
Publicado: (2023) -
Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions
por: Gorgulu Akin, Begum, et al.
Publicado: (2021)